Controversies Surrounding Lymph Node Dissection for Prostate Cancer

Urologic Clinics of North America

Volumn 37, Issue 1, 2010, Pages 57-65

  Palapattu, Ganesh S ^a   Singer, Eric A ^b   Messing, Edward M ^c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Lymph node; Lymph node dissection; Lymphadenectomy; Prostate cancer; Radical prostatectomy; Review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED SURGERY; DIAGNOSTIC ACCURACY; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RISK ASSESSMENT; ROBOTICS; SENSITIVITY AND SPECIFICITY; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL RISK;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; PELVIS; PROSTATIC NEOPLASMS;

EID: 75449095496     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2009.11.002     Document Type: Review

References (66)

1. Walsh P.C., and Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128 3 (1982) 492-497
2. Briganti A., Blute M.L., Eastham J.H., et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 55 6 (2009) 1251-1265
3. Makarov D.V., Trock B.J., Humphreys E.B., et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 69 6 (2007) 1095-1101
4. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 98 4 (2006) 788-793
5. Bhojani N., Salomon L., Capitanio U., et al. External validation of the updated partin tables in a cohort of French and Italian men. Int J Radiat Oncol Biol Phys 73 2 (2009) 347-352
6. Briganti A., Karakiewicz P.I., Chun F.K., et al. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol 51 6 (2007) 1573-1581
7. Wang L., Hricak H., Kattan M.W., et al. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. AJR Am J Roentgenol 186 3 (2006) 743-748
8. Karam J.A., Svatek R.S., Karakiewicz P.I., et al. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. Clin Cancer Res 14 5 (2008) 1418-1422
9. NCCN.NCCN clinical practice guidelines in oncology: prostate cancer. Available at: http://www.nccn.org/professionals/physicians_gls/pdf/prostate.pdf. Accessed September 5, 2009.
10. Kawakami J., Meng M.V., Sadetsky N., et al. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol 176 4 Pt 1 (2006) 1382-1386
11. Wolf Jr. J.S., Cher M., Dall'era M., et al. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 153 3 Pt 2 (1995) 993-999
12. Katz S., and Rosen M. MR imaging and MR spectroscopy in prostate cancer management. Radiol Clin North Am 44 5 (2006) 723-734 viii
13. Tempany C.M., and McNeil B.J. Advances in biomedical imaging. JAMA 285 5 (2001) 562-567
14. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 25 (2003) 2491-2499
15. Bellin M.F., Roy C., Kinkel K., et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 207 3 (1998) 799-808
16. Heesakkers R.A., Hovels A.M., Jager G.J., et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9 9 (2008) 850-856
17. Thoeny H.C., Triantafyllou M., Birkhaeuser F.D., et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55 4 (2009) 761-769
18. Schiavina R., Scattoni V., Castellucci P., et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54 2 (2008) 392-401
19. Marshall J., Cardin A., Singer E., et al. Laparoscopic pelvic lymphadenectomy with real time lymphatic imaging using near infrared fluorescence (NIRF) cameras. J Urol 181 Suppl 4 (2009) 274
20. Brossner C., Ringhofer H., Hernady T., et al. Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation. Urology 57 2 (2001) 389-393
21. Burkhard F.C., Schumacher M., and Studer U.E. The role of lymphadenectomy in prostate cancer. Nat Clin Pract Urol 2 7 (2005) 336-342
22. Zorn K.C., Katz M.H., Bernstein A., et al. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications. Urology 74 2 (2009) 296-302
23. Van Appledorn S., Bouchier-Hayes D., Agarwal D., et al. Robotic laparoscopic radical prostatectomy: setup and procedural techniques after 150 cases. Urology 67 2 (2006) 364-367
24. Golimbu M., Morales P., Al-Askari S., et al. Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121 5 (1979) 617-620
25. Fujioka T., Koike H., Aoki H., et al. Significance of staging pelvic lymphadenectomy for prostatic cancer. Urol Int 42 5 (1987) 380-384
26. Bader P., Burkhard F.C., Markwalder R., et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 2 (2002) 514-518 [discussion: 518]
27. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 4 (2002) 1681-1686
28. Allaf M.E., Palapattu G.S., Trock B.J., et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 5 Pt 1 (2004) 1840-1844
29. Mattei A., Fuechsel F.G., Bhatta Dhar N., et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 53 1 (2008) 118-125
30. McLaughlin A.P., Saltzstein S.L., McCullough D.L., et al. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 115 1 (1976) 89-94
31. Briganti A., Chun F.K., Salonia A., et al. A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Eur Urol 51 1 (2007) 112-119 [discussion: 119-20]
32. Bochner B.H., Herr H.W., and Reuter V.E. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166 6 (2001) 2295-2296
33. Stein J.P., Penson D.F., Cai J., et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177 3 (2007) 876-881 [discussion: 881-2]
34. Barth P.J., Gerharz E.W., Ramaswamy A., et al. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol Res Pract 195 9 (1999) 633-636
35. Thorn C.C., Woodcock N.P., Scott N., et al. What factors affect lymph node yield in surgery for rectal cancer?. Colorectal Dis 6 5 (2004) 356-361
36. Sivalingam S., Oxley J., Probert J.L., et al. Role of pelvic lymphadenectomy in prostate cancer management. Urology 69 2 (2007) 203-209
37. Finelli A., Moinzadeh A., Singh D., et al. Critique of laparoscopic lymphadenectomy in genitourinary oncology. Urol Oncol 22 3 (2004) 246-254 [discussion: 254-5]
38. Menon M., Tewari A., Peabody J.O., et al. Vattikuti Institute prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases. Urol Clin North Am 31 4 (2004) 701-717
39. Gonzalgo M.L., Patil N., Su L.M., et al. Minimally invasive surgical approaches and management of prostate cancer. Urol Clin North Am 35 3 (2008) 489-504 ix
40. Messing E.M., Manola J., Yao J., et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7 6 (2006) 472-479
41. Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 24 (1999) 1781-1788
42. Cagiannos I., Karakiewicz P., Eastham J.A., et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170 5 (2003) 1798-1803
43. Han M., Snow P.B., Brandt J.M., et al. Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma. Cancer 91 Suppl 8 (2001) 1661-1666
44. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 6 Pt 1 (2004) 2252-2255
45. Masterson T.A., Bianco Jr. F.J., Vickers A.J., et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 175 4 (2006) 1320-1324 [discussion: 1324-5]
46. Bader P., Burkhard F.C., Markwalder R., et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 3 (2003) 849-854
47. Boorjian S.A., Thompson R.H., Siddiqui S., et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178 3 Pt 1 (2007) 864-870 [discussion: 870-1]
48. Cheng L., Zincke H., Blute M.L., et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 1 (2001) 66-73
49. Briganti A., Karnes J.R., Da Pozzo L.F., et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 55 2 (2009) 261-270
50. Palapattu G.S., Allaf M.E., Trock B.J., et al. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 172 5 Pt 1 (2004) 1860-1864
51. Schumacher M.C., Burkhard F.C., Thalmann G.N., et al. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54 2 (2008) 344-352
52. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 3 (2002) 1295-1298
53. Axelsson C.K., During M., Christiansen P.M., et al. Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer. Br J Surg 96 1 (2009) 40-46
54. Joseph N.E., Sigurdson E.R., Hanlon A.L., et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10 3 (2003) 213-218
55. Gajra A., Newman N., Gamble G.P., et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21 6 (2003) 1029-1034
56. Joslyn S.A., and Konety B.R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68 1 (2006) 121-125
57. DiMarco D.S., Zincke H., Sebo T.J., et al. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173 4 (2005) 1121-1125
58. Bhatta-Dhar N., Reuther A.M., Zippe C., et al. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology 63 3 (2004) 528-531
59. Gofrit O.N., Zorn K.C., Steinberg G.D., et al. The Will Rogers phenomenon in urological oncology. J Urol 179 1 (2008) 28-33
60. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 1 (2003) 145-147 [discussion: 147-8]
61. Briganti A., Chun F.K., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 5 (2006) 1006-1013
62. Pepper R.J., Pati J., and Kaisary A.V. The incidence and treatment of lymphoceles after radical retropubic prostatectomy. BJU Int 95 6 (2005) 772-775
63. Stone N.N., Stock R.G., and Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 158 5 (1997) 1891-1894
64. Box G.N., Lee H.J., Abraham J.B., et al. Comparative study of in vivo lymphatic sealing capability of the porcine thoracic duct using laparoscopic dissection devices. J Urol 181 1 (2009) 387-391
65. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 1 (2008) 68-80
66. Thompson I., Thrasher J.B., Aus G., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177 6 (2007) 2106-2131